MedPath

ACID CONCENTRATE RZ119C

ACID CONCENTRATE RZ119C

Discontinued
DIN Number

N/A

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

genpharm ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
AIG Number0617386324
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormLiquid
Route of AdministrationHaemodialysis
AHFS Classification40:34.00* See footnote6
Health Canada Classification

ACTIVE INGREDIENTS (6)

ACETIC ACIDActive
Strength: 10.81 G / L
Monograph: ACETIC ACID
CALCIUM CHLORIDEActive
Strength: 9.924 G / L
Monograph: CALCIUM CHLORIDE
DEXTROSEActive
Strength: 99 G / L
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 3.431 G / L
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 3.355 G / L
Monograph: POTASSIUM CHLORIDE
SODIUM CHLORIDEActive
Strength: 263 G / L
Monograph: SODIUM CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.